Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial

Guenther, Lyn; Cambazard, F.; van de Kerkhof, P.C.M.; Snellman, Erna; Kragballe, Knud; Chu, A.C.; Tegner, E; García‐Diez, Amaro; Bertram Springborg, Jacob

doi:10.1046/j.1365-2133.2002.04967.x

Public

Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial

Published in British Journal of Dermatology • Aug 1, 2002

Authors:

Lyn Guenther

F. Cambazard

P.C.M. van de Kerkhof

Abstract

BACKGROUND: Calcipotriol and betamethasone dipropionate are both widely used, effective treatments for psoriasis. Vitamin D analogues and topical corticosteroids have different mechanisms of action in the treatment of psoriasis. A new vehicle has been developed in order to contain both calcipotriol ...

Subject

Calcipotriol

Betamethasone dipropionate

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!